Industry Research Reports
Global PRRS Vaccines Market Insights, Forecast to 2030
Industry: Machinery & Equipment
Published Date: 2024-04-22
Pages: 117 Pages
Report ld: 3040372
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.
The global PRRS Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for PRRS Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for PRRS Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for PRRS Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of PRRS Vaccines include CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary, Ringpu Biology and Qilu Animal, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the PRRS Vaccines production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of PRRS Vaccines by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for PRRS Vaccines, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of PRRS Vaccines, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for PRRS Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the PRRS Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global PRRS Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for PRRS Vaccines sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary, Ringpu Biology and Qilu Animal, etc.
MARKET SEGMENTATION
By Company
- CAHIC
- Merial
- MSD Animal Health
- Chopper Biology
- Ceva
- ChengDu Tecbond
- Veterinary
- Ringpu Biology
- Qilu Animal
- DHN
- CAVAC
- Komipharm
- Agrovet
- Bioveta
- Jinyu Bio-Technology
- Institutul Pasteur
- MVP
- Tecon
- Zoetis
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Live Vaccines
- Killed Vaccines
Segment by Application
- Government Tender
- Market Sales
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: PRRS Vaccines production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of PRRS Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of PRRS Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PRRS Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 PRRS Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global PRRS Vaccines Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market by Application
1.3.1 Global PRRS Vaccines Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global PRRS Vaccines Production
2.1 Global PRRS Vaccines Production Capacity (2019-2030)
2.2 Global PRRS Vaccines Production by Region: 2019 VS 2023 VS 2030
2.3 Global PRRS Vaccines Production by Region
2.3.1 Global PRRS Vaccines Historic Production by Region (2019-2024)
2.3.2 Global PRRS Vaccines Forecasted Production by Region (2025-2030)
2.3.3 Global PRRS Vaccines Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global PRRS Vaccines Revenue Estimates and Forecasts 2019-2030
3.2 Global PRRS Vaccines Revenue by Region
3.2.1 Global PRRS Vaccines Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global PRRS Vaccines Revenue by Region (2019-2024)
3.2.3 Global PRRS Vaccines Revenue by Region (2025-2030)
3.2.4 Global PRRS Vaccines Revenue Market Share by Region (2019-2030)
3.3 Global PRRS Vaccines Sales Estimates and Forecasts 2019-2030
3.4 Global PRRS Vaccines Sales by Region
3.4.1 Global PRRS Vaccines Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global PRRS Vaccines Sales by Region (2019-2024)
3.4.3 Global PRRS Vaccines Sales by Region (2025-2030)
3.4.4 Global PRRS Vaccines Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global PRRS Vaccines Sales by Manufacturers
4.1.1 Global PRRS Vaccines Sales by Manufacturers (2019-2024)
4.1.2 Global PRRS Vaccines Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of PRRS Vaccines in 2023
4.2 Global PRRS Vaccines Revenue by Manufacturers
4.2.1 Global PRRS Vaccines Revenue by Manufacturers (2019-2024)
4.2.2 Global PRRS Vaccines Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by PRRS Vaccines Revenue in 2023
4.3 Global PRRS Vaccines Sales Price by Manufacturers
4.4 Global Key Players of PRRS Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of PRRS Vaccines, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of PRRS Vaccines, Product Offered and Application
4.8 Global Key Manufacturers of PRRS Vaccines, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global PRRS Vaccines Sales by Type
5.1.1 Global PRRS Vaccines Historical Sales by Type (2019-2024)
5.1.2 Global PRRS Vaccines Forecasted Sales by Type (2025-2030)
5.1.3 Global PRRS Vaccines Sales Market Share by Type (2019-2030)
5.2 Global PRRS Vaccines Revenue by Type
5.2.1 Global PRRS Vaccines Historical Revenue by Type (2019-2024)
5.2.2 Global PRRS Vaccines Forecasted Revenue by Type (2025-2030)
5.2.3 Global PRRS Vaccines Revenue Market Share by Type (2019-2030)
5.3 Global PRRS Vaccines Price by Type
5.3.1 Global PRRS Vaccines Price by Type (2019-2024)
5.3.2 Global PRRS Vaccines Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global PRRS Vaccines Sales by Application
6.1.1 Global PRRS Vaccines Historical Sales by Application (2019-2024)
6.1.2 Global PRRS Vaccines Forecasted Sales by Application (2025-2030)
6.1.3 Global PRRS Vaccines Sales Market Share by Application (2019-2030)
6.2 Global PRRS Vaccines Revenue by Application
6.2.1 Global PRRS Vaccines Historical Revenue by Application (2019-2024)
6.2.2 Global PRRS Vaccines Forecasted Revenue by Application (2025-2030)
6.2.3 Global PRRS Vaccines Revenue Market Share by Application (2019-2030)
6.3 Global PRRS Vaccines Price by Application
6.3.1 Global PRRS Vaccines Price by Application (2019-2024)
6.3.2 Global PRRS Vaccines Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada PRRS Vaccines Market Size by Type
7.1.1 US & Canada PRRS Vaccines Sales by Type (2019-2030)
7.1.2 US & Canada PRRS Vaccines Revenue by Type (2019-2030)
7.2 US & Canada PRRS Vaccines Market Size by Application
7.2.1 US & Canada PRRS Vaccines Sales by Application (2019-2030)
7.2.2 US & Canada PRRS Vaccines Revenue by Application (2019-2030)
7.3 US & Canada PRRS Vaccines Sales by Country
7.3.1 US & Canada PRRS Vaccines Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada PRRS Vaccines Sales by Country (2019-2030)
7.3.3 US & Canada PRRS Vaccines Revenue by Country (2019-2030)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe PRRS Vaccines Market Size by Type
8.1.1 Europe PRRS Vaccines Sales by Type (2019-2030)
8.1.2 Europe PRRS Vaccines Revenue by Type (2019-2030)
8.2 Europe PRRS Vaccines Market Size by Application
8.2.1 Europe PRRS Vaccines Sales by Application (2019-2030)
8.2.2 Europe PRRS Vaccines Revenue by Application (2019-2030)
8.3 Europe PRRS Vaccines Sales by Country
8.3.1 Europe PRRS Vaccines Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe PRRS Vaccines Sales by Country (2019-2030)
8.3.3 Europe PRRS Vaccines Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China PRRS Vaccines Market Size by Type
9.1.1 China PRRS Vaccines Sales by Type (2019-2030)
9.1.2 China PRRS Vaccines Revenue by Type (2019-2030)
9.2 China PRRS Vaccines Market Size by Application
9.2.1 China PRRS Vaccines Sales by Application (2019-2030)
9.2.2 China PRRS Vaccines Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia PRRS Vaccines Market Size by Type
10.1.1 Asia PRRS Vaccines Sales by Type (2019-2030)
10.1.2 Asia PRRS Vaccines Revenue by Type (2019-2030)
10.2 Asia PRRS Vaccines Market Size by Application
10.2.1 Asia PRRS Vaccines Sales by Application (2019-2030)
10.2.2 Asia PRRS Vaccines Revenue by Application (2019-2030)
10.3 Asia PRRS Vaccines Sales by Region
10.3.1 Asia PRRS Vaccines Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia PRRS Vaccines Revenue by Region (2019-2030)
10.3.3 Asia PRRS Vaccines Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America PRRS Vaccines Market Size by Type
11.1.1 Middle East, Africa and Latin America PRRS Vaccines Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America PRRS Vaccines Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America PRRS Vaccines Market Size by Application
11.2.1 Middle East, Africa and Latin America PRRS Vaccines Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America PRRS Vaccines Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America PRRS Vaccines Sales by Country
11.3.1 Middle East, Africa and Latin America PRRS Vaccines Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America PRRS Vaccines Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America PRRS Vaccines Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 CAHIC
12.1.1 CAHIC Company Information
12.1.2 CAHIC Overview
12.1.3 CAHIC PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 CAHIC PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 CAHIC Recent Developments
12.2 Merial
12.2.1 Merial Company Information
12.2.2 Merial Overview
12.2.3 Merial PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Merial PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Merial Recent Developments
12.3 MSD Animal Health
12.3.1 MSD Animal Health Company Information
12.3.2 MSD Animal Health Overview
12.3.3 MSD Animal Health PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 MSD Animal Health PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 MSD Animal Health Recent Developments
12.4 Chopper Biology
12.4.1 Chopper Biology Company Information
12.4.2 Chopper Biology Overview
12.4.3 Chopper Biology PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Chopper Biology PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Chopper Biology Recent Developments
12.5 Ceva
12.5.1 Ceva Company Information
12.5.2 Ceva Overview
12.5.3 Ceva PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Ceva PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Ceva Recent Developments
12.6 ChengDu Tecbond
12.6.1 ChengDu Tecbond Company Information
12.6.2 ChengDu Tecbond Overview
12.6.3 ChengDu Tecbond PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 ChengDu Tecbond PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 ChengDu Tecbond Recent Developments
12.7 Veterinary
12.7.1 Veterinary Company Information
12.7.2 Veterinary Overview
12.7.3 Veterinary PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 Veterinary PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Veterinary Recent Developments
12.8 Ringpu Biology
12.8.1 Ringpu Biology Company Information
12.8.2 Ringpu Biology Overview
12.8.3 Ringpu Biology PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.8.4 Ringpu Biology PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Ringpu Biology Recent Developments
12.9 Qilu Animal
12.9.1 Qilu Animal Company Information
12.9.2 Qilu Animal Overview
12.9.3 Qilu Animal PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.9.4 Qilu Animal PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Qilu Animal Recent Developments
12.10 DHN
12.10.1 DHN Company Information
12.10.2 DHN Overview
12.10.3 DHN PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.10.4 DHN PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 DHN Recent Developments
12.11 CAVAC
12.11.1 CAVAC Company Information
12.11.2 CAVAC Overview
12.11.3 CAVAC PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.11.4 CAVAC PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 CAVAC Recent Developments
12.12 Komipharm
12.12.1 Komipharm Company Information
12.12.2 Komipharm Overview
12.12.3 Komipharm PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.12.4 Komipharm PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Komipharm Recent Developments
12.13 Agrovet
12.13.1 Agrovet Company Information
12.13.2 Agrovet Overview
12.13.3 Agrovet PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.13.4 Agrovet PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Agrovet Recent Developments
12.14 Bioveta
12.14.1 Bioveta Company Information
12.14.2 Bioveta Overview
12.14.3 Bioveta PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.14.4 Bioveta PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Bioveta Recent Developments
12.15 Jinyu Bio-Technology
12.15.1 Jinyu Bio-Technology Company Information
12.15.2 Jinyu Bio-Technology Overview
12.15.3 Jinyu Bio-Technology PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.15.4 Jinyu Bio-Technology PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Jinyu Bio-Technology Recent Developments
12.16 Institutul Pasteur
12.16.1 Institutul Pasteur Company Information
12.16.2 Institutul Pasteur Overview
12.16.3 Institutul Pasteur PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.16.4 Institutul Pasteur PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Institutul Pasteur Recent Developments
12.17 MVP
12.17.1 MVP Company Information
12.17.2 MVP Overview
12.17.3 MVP PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.17.4 MVP PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 MVP Recent Developments
12.18 Tecon
12.18.1 Tecon Company Information
12.18.2 Tecon Overview
12.18.3 Tecon PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.18.4 Tecon PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Tecon Recent Developments
12.19 Zoetis
12.19.1 Zoetis Company Information
12.19.2 Zoetis Overview
12.19.3 Zoetis PRRS Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
12.19.4 Zoetis PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 Zoetis Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 PRRS Vaccines Industry Chain Analysis
13.2 PRRS Vaccines Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 PRRS Vaccines Production Mode & Process
13.4 PRRS Vaccines Sales and Marketing
13.4.1 PRRS Vaccines Sales Channels
13.4.2 PRRS Vaccines Distributors
13.5 PRRS Vaccines Customers
14 PRRS Vaccines Market Dynamics
14.1 PRRS Vaccines Industry Trends
14.2 PRRS Vaccines Market Drivers
14.3 PRRS Vaccines Market Challenges
14.4 PRRS Vaccines Market Restraints
15 Key Finding in The Global PRRS Vaccines Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global PRRS Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Killed Vaccines
Table 4. Global PRRS Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global PRRS Vaccines Production by Region: 2019 VS 2023 VS 2030 (K Units)
Table 6. Global PRRS Vaccines Production by Region (2019-2024) & (K Units)
Table 7. Global PRRS Vaccines Production by Region (2025-2030) & (K Units)
Table 8. Global PRRS Vaccines Production Market Share by Region (2019-2024)
Table 9. Global PRRS Vaccines Production Market Share by Region (2025-2030)
Table 10. Global PRRS Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global PRRS Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 12. Global PRRS Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 13. Global PRRS Vaccines Revenue Market Share by Region (2019-2024)
Table 14. Global PRRS Vaccines Revenue Market Share by Region (2025-2030)
Table 15. Global PRRS Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global PRRS Vaccines Sales by Region (2019-2024) & (K Units)
Table 17. Global PRRS Vaccines Sales by Region (2025-2030) & (K Units)
Table 18. Global PRRS Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global PRRS Vaccines Sales Market Share by Region (2025-2030)
Table 20. Global PRRS Vaccines Sales by Manufacturers (2019-2024) & (K Units)
Table 21. Global PRRS Vaccines Sales Share by Manufacturers (2019-2024)
Table 22. Global PRRS Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 23. Global PRRS Vaccines Revenue Share by Manufacturers (2019-2024)
Table 24. PRRS Vaccines Price by Manufacturers 2019-2024 (USD/Unit)
Table 25. Global Key Players of PRRS Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 26. Global PRRS Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global PRRS Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PRRS Vaccines as of 2023)
Table 28. Global Key Manufacturers of PRRS Vaccines, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of PRRS Vaccines, Product Offered and Application
Table 30. Global Key Manufacturers of PRRS Vaccines, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global PRRS Vaccines Sales by Type (2019-2024) & (K Units)
Table 33. Global PRRS Vaccines Sales by Type (2025-2030) & (K Units)
Table 34. Global PRRS Vaccines Sales Share by Type (2019-2024)
Table 35. Global PRRS Vaccines Sales Share by Type (2025-2030)
Table 36. Global PRRS Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 37. Global PRRS Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 38. Global PRRS Vaccines Revenue Share by Type (2019-2024)
Table 39. Global PRRS Vaccines Revenue Share by Type (2025-2030)
Table 40. PRRS Vaccines Price by Type (2019-2024) & (USD/Unit)
Table 41. Global PRRS Vaccines Price Forecast by Type (2025-2030) & (USD/Unit)
Table 42. Global PRRS Vaccines Sales by Application (2019-2024) & (K Units)
Table 43. Global PRRS Vaccines Sales by Application (2025-2030) & (K Units)
Table 44. Global PRRS Vaccines Sales Share by Application (2019-2024)
Table 45. Global PRRS Vaccines Sales Share by Application (2025-2030)
Table 46. Global PRRS Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global PRRS Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global PRRS Vaccines Revenue Share by Application (2019-2024)
Table 49. Global PRRS Vaccines Revenue Share by Application (2025-2030)
Table 50. PRRS Vaccines Price by Application (2019-2024) & (USD/Unit)
Table 51. Global PRRS Vaccines Price Forecast by Application (2025-2030) & (USD/Unit)
Table 52. US & Canada PRRS Vaccines Sales by Type (2019-2024) & (K Units)
Table 53. US & Canada PRRS Vaccines Sales by Type (2025-2030) & (K Units)
Table 54. US & Canada PRRS Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 55. US & Canada PRRS Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 56. US & Canada PRRS Vaccines Sales by Application (2019-2024) & (K Units)
Table 57. US & Canada PRRS Vaccines Sales by Application (2025-2030) & (K Units)
Table 58. US & Canada PRRS Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 59. US & Canada PRRS Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 60. US & Canada PRRS Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 61. US & Canada PRRS Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 62. US & Canada PRRS Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 63. US & Canada PRRS Vaccines Sales by Country (2019-2024) & (K Units)
Table 64. US & Canada PRRS Vaccines Sales by Country (2025-2030) & (K Units)
Table 65. Europe PRRS Vaccines Sales by Type (2019-2024) & (K Units)
Table 66. Europe PRRS Vaccines Sales by Type (2025-2030) & (K Units)
Table 67. Europe PRRS Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 68. Europe PRRS Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 69. Europe PRRS Vaccines Sales by Application (2019-2024) & (K Units)
Table 70. Europe PRRS Vaccines Sales by Application (2025-2030) & (K Units)
Table 71. Europe PRRS Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 72. Europe PRRS Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 73. Europe PRRS Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 74. Europe PRRS Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 75. Europe PRRS Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 76. Europe PRRS Vaccines Sales by Country (2019-2024) & (K Units)
Table 77. Europe PRRS Vaccines Sales by Country (2025-2030) & (K Units)
Table 78. China PRRS Vaccines Sales by Type (2019-2024) & (K Units)
Table 79. China PRRS Vaccines Sales by Type (2025-2030) & (K Units)
Table 80. China PRRS Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 81. China PRRS Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 82. China PRRS Vaccines Sales by Application (2019-2024) & (K Units)
Table 83. China PRRS Vaccines Sales by Application (2025-2030) & (K Units)
Table 84. China PRRS Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 85. China PRRS Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 86. Asia PRRS Vaccines Sales by Type (2019-2024) & (K Units)
Table 87. Asia PRRS Vaccines Sales by Type (2025-2030) & (K Units)
Table 88. Asia PRRS Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 89. Asia PRRS Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 90. Asia PRRS Vaccines Sales by Application (2019-2024) & (K Units)
Table 91. Asia PRRS Vaccines Sales by Application (2025-2030) & (K Units)
Table 92. Asia PRRS Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 93. Asia PRRS Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 94. Asia PRRS Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 95. Asia PRRS Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 96. Asia PRRS Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 97. Asia PRRS Vaccines Sales by Region (2019-2024) & (K Units)
Table 98. Asia PRRS Vaccines Sales by Region (2025-2030) & (K Units)
Table 99. Middle East, Africa and Latin America PRRS Vaccines Sales by Type (2019-2024) & (K Units)
Table 100. Middle East, Africa and Latin America PRRS Vaccines Sales by Type (2025-2030) & (K Units)
Table 101. Middle East, Africa and Latin America PRRS Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America PRRS Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America PRRS Vaccines Sales by Application (2019-2024) & (K Units)
Table 104. Middle East, Africa and Latin America PRRS Vaccines Sales by Application (2025-2030) & (K Units)
Table 105. Middle East, Africa and Latin America PRRS Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America PRRS Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America PRRS Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 108. Middle East, Africa and Latin America PRRS Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America PRRS Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 110. Middle East, Africa and Latin America PRRS Vaccines Sales by Country (2019-2024) & (K Units)
Table 111. Middle East, Africa and Latin America PRRS Vaccines Sales by Country (2025-2030) & (K Units)
Table 112. CAHIC Company Information
Table 113. CAHIC Description and Major Businesses
Table 114. CAHIC PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. CAHIC PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CAHIC Recent Development
Table 117. Merial Company Information
Table 118. Merial Description and Major Businesses
Table 119. Merial PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Merial PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Merial Recent Development
Table 122. MSD Animal Health Company Information
Table 123. MSD Animal Health Description and Major Businesses
Table 124. MSD Animal Health PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. MSD Animal Health PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. MSD Animal Health Recent Development
Table 127. Chopper Biology Company Information
Table 128. Chopper Biology Description and Major Businesses
Table 129. Chopper Biology PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Chopper Biology PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Chopper Biology Recent Development
Table 132. Ceva Company Information
Table 133. Ceva Description and Major Businesses
Table 134. Ceva PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Ceva PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Ceva Recent Development
Table 137. ChengDu Tecbond Company Information
Table 138. ChengDu Tecbond Description and Major Businesses
Table 139. ChengDu Tecbond PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. ChengDu Tecbond PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. ChengDu Tecbond Recent Development
Table 142. Veterinary Company Information
Table 143. Veterinary Description and Major Businesses
Table 144. Veterinary PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. Veterinary PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Veterinary Recent Development
Table 147. Ringpu Biology Company Information
Table 148. Ringpu Biology Description and Major Businesses
Table 149. Ringpu Biology PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 150. Ringpu Biology PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Ringpu Biology Recent Development
Table 152. Qilu Animal Company Information
Table 153. Qilu Animal Description and Major Businesses
Table 154. Qilu Animal PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 155. Qilu Animal PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Qilu Animal Recent Development
Table 157. DHN Company Information
Table 158. DHN Description and Major Businesses
Table 159. DHN PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 160. DHN PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. DHN Recent Development
Table 162. CAVAC Company Information
Table 163. CAVAC Description and Major Businesses
Table 164. CAVAC PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 165. CAVAC PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. CAVAC Recent Development
Table 167. Komipharm Company Information
Table 168. Komipharm Description and Major Businesses
Table 169. Komipharm PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 170. Komipharm PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Komipharm Recent Development
Table 172. Agrovet Company Information
Table 173. Agrovet Description and Major Businesses
Table 174. Agrovet PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 175. Agrovet PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Agrovet Recent Development
Table 177. Bioveta Company Information
Table 178. Bioveta Description and Major Businesses
Table 179. Bioveta PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 180. Bioveta PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Bioveta Recent Development
Table 182. Jinyu Bio-Technology Company Information
Table 183. Jinyu Bio-Technology Description and Major Businesses
Table 184. Jinyu Bio-Technology PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 185. Jinyu Bio-Technology PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Jinyu Bio-Technology Recent Development
Table 187. Institutul Pasteur Company Information
Table 188. Institutul Pasteur Description and Major Businesses
Table 189. Institutul Pasteur PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 190. Institutul Pasteur PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Institutul Pasteur Recent Development
Table 192. MVP Company Information
Table 193. MVP Description and Major Businesses
Table 194. MVP PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 195. MVP PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. MVP Recent Development
Table 197. Tecon Company Information
Table 198. Tecon Description and Major Businesses
Table 199. Tecon PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 200. Tecon PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Tecon Recent Development
Table 202. Zoetis Company Information
Table 203. Zoetis Description and Major Businesses
Table 204. Zoetis PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 205. Zoetis PRRS Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Zoetis Recent Development
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. PRRS Vaccines Distributors List
Table 210. PRRS Vaccines Customers List
Table 211. PRRS Vaccines Market Trends
Table 212. PRRS Vaccines Market Drivers
Table 213. PRRS Vaccines Market Challenges
Table 214. PRRS Vaccines Market Restraints
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. PRRS Vaccines Product Picture
Figure 2. Global PRRS Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global PRRS Vaccines Market Share by Type in 2023 & 2030
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global PRRS Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global PRRS Vaccines Market Share by Application in 2023 & 2030
Figure 8. Government Tender
Figure 9. Market Sales
Figure 10. PRRS Vaccines Report Years Considered
Figure 11. Global PRRS Vaccines Capacity, Production and Utilization (2019-2030) & (K Units)
Figure 12. Global PRRS Vaccines Production Market Share by Region in Percentage: 2023 Versus 2030
Figure 13. Global PRRS Vaccines Production Market Share by Region (2019-2030)
Figure 14. PRRS Vaccines Production Growth Rate in North America (2019-2030) & (K Units)
Figure 15. PRRS Vaccines Production Growth Rate in Europe (2019-2030) & (K Units)
Figure 16. PRRS Vaccines Production Growth Rate in China (2019-2030) & (K Units)
Figure 17. PRRS Vaccines Production Growth Rate in Japan (2019-2030) & (K Units)
Figure 18. Global PRRS Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global PRRS Vaccines Revenue 2019-2030 (US$ Million)
Figure 20. Global PRRS Vaccines Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global PRRS Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 22. Global PRRS Vaccines Revenue Market Share by Region (2019-2030)
Figure 23. Global PRRS Vaccines Sales 2019-2030 ((K Units)
Figure 24. Global PRRS Vaccines Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 25. Global PRRS Vaccines Sales Market Share by Region (2019-2030)
Figure 26. US & Canada PRRS Vaccines Sales YoY (2019-2030) & (K Units)
Figure 27. US & Canada PRRS Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Europe PRRS Vaccines Sales YoY (2019-2030) & (K Units)
Figure 29. Europe PRRS Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 30. China PRRS Vaccines Sales YoY (2019-2030) & (K Units)
Figure 31. China PRRS Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 32. Asia (excluding China) PRRS Vaccines Sales YoY (2019-2030) & (K Units)
Figure 33. Asia (excluding China) PRRS Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 34. Middle East, Africa and Latin America PRRS Vaccines Sales YoY (2019-2030) & (K Units)
Figure 35. Middle East, Africa and Latin America PRRS Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 36. The PRRS Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 37. The Top 5 and 10 Largest Manufacturers of PRRS Vaccines in the World: Market Share by PRRS Vaccines Revenue in 2023
Figure 38. Global PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 39. Global PRRS Vaccines Sales Market Share by Type (2019-2030)
Figure 40. Global PRRS Vaccines Revenue Market Share by Type (2019-2030)
Figure 41. Global PRRS Vaccines Sales Market Share by Application (2019-2030)
Figure 42. Global PRRS Vaccines Revenue Market Share by Application (2019-2030)
Figure 43. US & Canada PRRS Vaccines Sales Market Share by Type (2019-2030)
Figure 44. US & Canada PRRS Vaccines Revenue Market Share by Type (2019-2030)
Figure 45. US & Canada PRRS Vaccines Sales Market Share by Application (2019-2030)
Figure 46. US & Canada PRRS Vaccines Revenue Market Share by Application (2019-2030)
Figure 47. US & Canada PRRS Vaccines Revenue Share by Country (2019-2030)
Figure 48. US & Canada PRRS Vaccines Sales Share by Country (2019-2030)
Figure 49. U.S. PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 50. Canada PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 51. Europe PRRS Vaccines Sales Market Share by Type (2019-2030)
Figure 52. Europe PRRS Vaccines Revenue Market Share by Type (2019-2030)
Figure 53. Europe PRRS Vaccines Sales Market Share by Application (2019-2030)
Figure 54. Europe PRRS Vaccines Revenue Market Share by Application (2019-2030)
Figure 55. Europe PRRS Vaccines Revenue Share by Country (2019-2030)
Figure 56. Europe PRRS Vaccines Sales Share by Country (2019-2030)
Figure 57. Germany PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 58. France PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 59. U.K. PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 60. Italy PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 61. Russia PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 62. China PRRS Vaccines Sales Market Share by Type (2019-2030)
Figure 63. China PRRS Vaccines Revenue Market Share by Type (2019-2030)
Figure 64. China PRRS Vaccines Sales Market Share by Application (2019-2030)
Figure 65. China PRRS Vaccines Revenue Market Share by Application (2019-2030)
Figure 66. Asia PRRS Vaccines Sales Market Share by Type (2019-2030)
Figure 67. Asia PRRS Vaccines Revenue Market Share by Type (2019-2030)
Figure 68. Asia PRRS Vaccines Sales Market Share by Application (2019-2030)
Figure 69. Asia PRRS Vaccines Revenue Market Share by Application (2019-2030)
Figure 70. Asia PRRS Vaccines Revenue Share by Region (2019-2030)
Figure 71. Asia PRRS Vaccines Sales Share by Region (2019-2030)
Figure 72. Japan PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 73. South Korea PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 74. China Taiwan PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 75. Southeast Asia PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 76. India PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 77. Middle East, Africa and Latin America PRRS Vaccines Sales Market Share by Type (2019-2030)
Figure 78. Middle East, Africa and Latin America PRRS Vaccines Revenue Market Share by Type (2019-2030)
Figure 79. Middle East, Africa and Latin America PRRS Vaccines Sales Market Share by Application (2019-2030)
Figure 80. Middle East, Africa and Latin America PRRS Vaccines Revenue Market Share by Application (2019-2030)
Figure 81. Middle East, Africa and Latin America PRRS Vaccines Revenue Share by Country (2019-2030)
Figure 82. Middle East, Africa and Latin America PRRS Vaccines Sales Share by Country (2019-2030)
Figure 83. Brazil PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 84. Mexico PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 85. Turkey PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 86. Israel PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 87. GCC Countries PRRS Vaccines Revenue (2019-2030) & (US$ Million)
Figure 88. PRRS Vaccines Value Chain
Figure 89. PRRS Vaccines Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global PRRS Vaccines market?
The top companies in the global PRRS Vaccines market are CAHIC、Merial、MSD Animal Health.
Related Reports
Global PRRS Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global PRRS Vaccines market size was US$ 429 million in 2025 and is forecast to reach a readjusted size of US$ 543 million by 2032 with a CAGR of 3.5% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 104
USD 4250.00
(Single User License)
Global PRRS Vaccines Market Outlook, In‑Depth Analysis & Forecast to 2032
The global PRRS Vaccines market is projected to grow from US$ 429 million in 2025 to US$ 543 million by 2032, at a CAGR of 3.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 179
USD 4900.00
(Single User License)
PRRS Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for PRRS Vaccines was estimated to be worth US$ 429 million in 2025 and is projected to reach US$ 543 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 131
USD 3950.00
(Single User License)
Global PRRS Vaccines Market Research Report 2026
The global PRRS Vaccines market was valued at US$ 429 million in 2025 and is anticipated to reach US$ 543 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 146
USD 2900.00
(Single User License)
Global PRRS Vaccines Market Outlook, In‑Depth Analysis & Forecast to 2031
The global PRRS Vaccines market is projected to grow from US$ 410 million in 2024 to US$ 527 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 176
USD 4900.00
(Single User License)
PRRS Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for PRRS Vaccines was estimated to be worth US$ 410 million in 2024 and is forecast to a readjusted size of US$ 527 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-05-23
Pages: 134
USD 3950.00
(Single User License)
Global PRRS Vaccines Market Insights, Forecast to 2031
The global PRRS Vaccines market is projected to grow from US$ 429 million in 2025 to US$ 527 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Published Date: 2025-05-23
Pages: 175
USD 4900.00
(Single User License)
Global PRRS Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global PRRS Vaccines market size was US$ 410 million in 2024 and is forecast to a readjusted size of US$ 527 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-05-23
Pages: 109
USD 4250.00
(Single User License)
Global PRRS Vaccines Market Research Report 2025
The global market for PRRS Vaccines was valued at US$ 410 million in the year 2024 and is projected to reach a revised size of US$ 527 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published Date: 2025-05-23
Pages: 115
USD 2900.00
(Single User License)
PRRS Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for PRRS Vaccines was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 140
USD 3950.00
(Single User License)
Global PRRS Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global PRRS Vaccines market size was US$ 429 million in 2025 and is forecast to reach a readjusted size of US$ 543 million by 2032 with a CAGR of 3.5% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 104
USD 4250.00 (Single User License)Global PRRS Vaccines Market Outlook, In‑Depth Analysis & Forecast to 2032
The global PRRS Vaccines market is projected to grow from US$ 429 million in 2025 to US$ 543 million by 2032, at a CAGR of 3.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 179
USD 4900.00 (Single User License)PRRS Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for PRRS Vaccines was estimated to be worth US$ 429 million in 2025 and is projected to reach US$ 543 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-03-05
Pages: 131
USD 3950.00 (Single User License)Global PRRS Vaccines Market Research Report 2026
The global PRRS Vaccines market was valued at US$ 429 million in 2025 and is anticipated to reach US$ 543 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-03-05
Pages: 146
USD 2900.00 (Single User License)Global PRRS Vaccines Market Outlook, In‑Depth Analysis & Forecast to 2031
The global PRRS Vaccines market is projected to grow from US$ 410 million in 2024 to US$ 527 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 176
USD 4900.00 (Single User License)PRRS Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for PRRS Vaccines was estimated to be worth US$ 410 million in 2024 and is forecast to a readjusted size of US$ 527 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-05-23
Pages: 134
USD 3950.00 (Single User License)Global PRRS Vaccines Market Insights, Forecast to 2031
The global PRRS Vaccines market is projected to grow from US$ 429 million in 2025 to US$ 527 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Published: 2025-05-23
Pages: 175
USD 4900.00 (Single User License)Global PRRS Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global PRRS Vaccines market size was US$ 410 million in 2024 and is forecast to a readjusted size of US$ 527 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-05-23
Pages: 109
USD 4250.00 (Single User License)Global PRRS Vaccines Market Research Report 2025
The global market for PRRS Vaccines was valued at US$ 410 million in the year 2024 and is projected to reach a revised size of US$ 527 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published: 2025-05-23
Pages: 115
USD 2900.00 (Single User License)PRRS Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for PRRS Vaccines was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 140
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now